ENDRA raises $4.9M in private placement to launch digital asset treasury strategy

ENDRA Life Sciences Inc.

Sold 744,340 shares/pre-funded warrants plus up to 1,488,680 common warrants at $6.57 per unit; $6.81 for director participant.
Gross proceeds ~$4.9M; up to $14.4M if common warrants exercised; majority allocated to digital asset treasury (DAT) strategy.
Engaged Arca Investment Management to manage $3.5M of DAT assets; fees 1.25–1.75% AUM + 10–15% performance fee; issued 400,000 advisory warrants.
Terminated at-the-market equity facility with Ascendiant effective October 13, 2025.
2025 annual meeting set for December 9, 2025; record date October 16, 2025; stockholder proposal deadline October 27, 2025.

item 1.01 item 1.02 item 3.02 item 5.08 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.